Status:

ENROLLING_BY_INVITATION

EnCoRe MoMS:Engaging Communities to Reduce Morbidity From Maternal Sepsis

Lead Sponsor:

Columbia University

Collaborating Sponsors:

Northern Manhattan Perinatal Partnership

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Conditions:

Maternal Sepsis

Infections

Eligibility:

FEMALE

18+ years

Brief Summary

Sepsis is the second leading cause of maternal death in the U.S. For racial and ethnic minoritized birthing people, especially those who are Black, living in poverty, and from underserved communities,...

Detailed Description

Maternal sepsis is the second leading cause of maternal death, major cause of morbidity, and preventable in most cases. Labor, birth, and postpartum are periods of increased sepsis risk, particularly ...

Eligibility Criteria

Inclusion

  • Patient Interviews:
  • Speak Spanish or English
  • Be 18 years or older
  • Have a birthing experience in Columbia, Allen, Lincoln, or Harlem Hospitals within the past 8 weeks of enrollment
  • Have had at least one early warning sign or risk factor for infection present during their pregnancy, delivery, or postpartum
  • Community Stakeholder Focus Groups:
  • Speak English or Spanish
  • Be 18 years or older
  • Have academic/professional background relevant to maternal health in New York City.

Exclusion

  • Patient Interviews
  • Under 18 years old
  • Speaks a language other than Spanish or English
  • Gave birth in a hospital other than Columbia, Allen, Lincoln, or Harlem Hospitals
  • Did not have had at least one early warning sign or risk factor for infection present during their pregnancy, delivery, or postpartum
  • Community Stakeholder Focus Groups
  • Under 18 years old
  • Speaks a language other than Spanish or English
  • Does not have a academic/professional background relevant to maternal health in New York City.

Key Trial Info

Start Date :

July 20 2023

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

September 30 2026

Estimated Enrollment :

200 Patients enrolled

Trial Details

Trial ID

NCT06160349

Start Date

July 20 2023

End Date

September 30 2026

Last Update

December 18 2024

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Columbia Unviersity Medical Center

New York, New York, United States, 10032

2

NYC Health+Hospitals/Harlem

New York, New York, United States, 10037

3

NYC Health + Hospitals/Lincoln

The Bronx, New York, United States, 10451